Michael Henry

Michael Henry is the Chief Business Officer at Aldatu Biosciences and an active investor with the Berkeley Angel Network. He has accumulated over 20 years of business development and commercial strategy experience within the biotechnology sector, having previously held senior leadership roles at prominent organizations including Ancestry, Quest Diagnostics, and Thermo Fisher. During his earlier tenure at Athena Diagnostics, he was instrumental in driving the company's successful $740 million acquisition by Quest Diagnostics in the year 2011. Before transitioning into these corporate executive positions, he managed medical technology transfer initiatives at various academic medical centers. He holds an MBA and an MA from UC Berkeley, as well as a BS from the University of Michigan. Henry's professional background combines extensive corporate life sciences leadership with a current focus on advancing molecular diagnostics and early-stage biotech startup investments.